Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Hydroxylamine | HCID 787 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | HCID 131730438 | HCID 131730438 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 68503455 | HCID 68503455 | 55% |
Reaction Steps
Cis-methyl 2-cyclohexyl-4-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate (1.644 g, 4.84 mmol) was dissolved in MeOH (15 mL) and cooled to −40° C. Sodium hydroxide (0.194 g, 4.84 mmol) dissolved in water (1.500 mL) was added dropwise and the colourless solution continued to stir at −40° C. for 30 min. Hydroxylamine (50% by weight in water, 0.297 mL, 4.84 mmol) was added dropwise. The resulting solution was stirred at −40° C. for 3 h. The mixture was then rapidly poured into a prewarmed (80° C.) solution of 6 M hydrogen chloride (21 mL, 126.00 mmol) and the mixture continued to stir at 80° C. for 20 min. The solvent was evaporated and MTBE/water added. The phases were separated and the organic phase dried over Na2SO4 and evaporated to yield a slightly yellow foam. The compound was purified by preparative HPLC on a Kromasil C8 column (10 μm 250×50 ID mm) using two injections with a gradient of 15-75% Acetonitrile in H2O/MeCN/AcOH 95/5/0.2 buffer over 30 minutes with a flow of 100 mL/min. Cis-methyl 2-cyclohexyl-4-(3-oxo-2,3-dihydroisoxazol-5-yl)piperidine-1-carboxylate (814 mg, 55%) was isolated. 1H NMR (400 MHz, cdcl3) δ 0.83-0.98 (m, 2H), 1.01-1.16 (m, 3H), 1.25-1.40 (m, 1H), 1.50-1.88 (m, 6H), 1.95-2.13 (m, 3H), 2.88-3.07 (m, 2H), 3.70 (s, 3H), 3.79-3.89 (m, 1H), 3.95-4.07 (m, 1H), 5.70 (s, 1H). MS m/z 309 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08415378B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-97d566aa71fe4275b70af6f9a1b0cffd |
|---|
| Source note | uspto-grants-2013_04 |
|---|